Search
Searching with a thematic focus on Intellectual Property Rights, Trade Policy
Showing 361-370 of 420 results
Pages
- Document
WTO patent rules and access to medicines: the pressure mounts
Oxfam, 2001Oxfam is calling for TRIPS to be reformed so that developing country governments have the unambiguous right to obtain the cheapest possible life-saving medicines without facing the threats of legal challenges or trade sanctions experienced by South Africa and Brazil.DocumentThe use of proprietary biotechnology research inputs at selected Latin American NAROs
International Service for National Agricultural Research, 2000The main purpose of this Briefing Paper is to provide an assessment of the use of proprietary biotechnology inputs in the agricultural research systems of selected Latin American countries: Brazil, Chile, Colombia, Costa Rica, and Mexico.DocumentWorld Trade Organisation agreements: implications for equity and health in Southern Africa
EQUINET: Network for Equity in Health in Southern Africa, 2000This paper investigates the consequences of WTO agreements relating to health, and primarily the TRIPS agreement on health care and drug access for Southern African Development Community (SADC) countries.The paper provides a brief review of GATT /WTO and WTO agreements relating to health.DocumentCommunication from the European Communities and their Member States to the TRIPS council: the relationship between provisions of the TRIPS agreement and access to medicines
European Union, 2001Paper comes in response to The EC and their Member States recognition of the lack of affordable pharmaceuticals as a serious problem in many developing countries and especially for the poorest people.Paper assesses: relevance of intellectual property; compulsory licensing; exceptions to patent rights; and, protection of undisclosed informationSummary and recommendations:The spirallDocumentIncreasing access to health care in developing countries: the need for public-private partnership
International Federation of Pharmaceutical Manufacturers Associations, 2000When problems of access to novel or even older treatments are discussed, many reasons are cited – including financial, infrastructure, and cost factors.Conclusion: It is clear that price plays a less important role than infrastructure, financing and national political will in ensuring access to drugs, particularly in developing countries.DocumentEncouragement of new clinical drug development: the role of data exclusivity
International Federation of Pharmaceutical Manufacturers Associations, 2000Paper asserts that for the pharmaceutical industry to invest the billions of dollars, Euros, yen, etc. in these highly risky health care solutions, intellectual property protection is essential. However, patent and trade-mark protections are not the entire story.DocumentPatent injustice: how world trade rules threaten the health of poor people
Oxfam, 2001This briefing paper shows how new global patent rules, introduced by the World Trade Organisation, will raise the costs of vital medicines, with potentially disastrous implications for poor countries.DocumentA patent policy proposal for global diseases
Brookings Institution, 2001This policy brief outlines a proposal that would lower the price of pharmaceuticals that treat important global diseases in developing countries, while at the same time allowing patent protection to increase where it is most likely to lead to the creation of new products. The proposal requires no changes in international treaties, only minor changes to U.S.DocumentIntellectual property needs and expectations of traditional knowledge holders
World Intellectual Property Organization, 2000This Report presents information compiled by the World Intellectual Property Organization (WIPO) from nine fact-finding missions on the intellectual property (IP) needs and expectations of holders of traditional knowledge (TK).The first section of the chapter "Framing the Intellectual Property Needs and Expectations of Traditional Knowledge Holders " provides a basic and general introduction toDocumentCopyrights, competition and development: the case of the music industry
United Nations [UN] Conference on Trade and Development, 2000Paper analyses the relationship between the copyright and income generation in the audio-visual sector, in particular music.Pages
